FTA will hurt pharmaceutical sector

Published: 2007-08-23 06:58:00

Updated: 2007-08-23 06:58:00

It's obvious that prices of the drugs will soar, which will damage domestic clients' access to drugs, if a U.S.-Korea free trade agreement goes through and the patent period of new drugs made by the United States is extended, said an official of the Korea Pharmaceuticals Manufacturers Association...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK